Gryaznov Sergei 4
4 · MAIA Biotechnology, Inc. · Filed Dec 8, 2022
Insider Transaction Report
Form 4
Gryaznov Sergei
Chief Scientific Officer
Transactions
- Exercise/Conversion
Stock Options
2022-12-07−10,000→ 40,000 totalExercise: $1.83Exp: 2031-04-15→ Common Stock (10,000 underlying) - Exercise/Conversion
Common Stock
2022-12-07$1.83/sh+10,000$18,300→ 44,511 total
Footnotes (1)
- [F1]Represents an option to purchase shares of Common Stock granted pursuant to the 2020 Equity Incentive Plan. These options vest in 36 equal monthly instalments beginning on January 1, 2021.